THE ONCOALERT NETWORK
Welcome to โOncoAlert
Related Articles
Supplemental Offer and Acceptance Program (SOAP) Prep | Osteopathic Webinar
Curious to learn more about the SOAP process, but too afraid to ask? Join those who have undergone the process as they give you the…
Germline Testing in Patients With Breast Cancer: ASCOโSociety of Surgical Oncology Guideline
PURPOSE To develop recommendations for germline mutation testing for patients with breast cancer. METHODS An ASCOโSociety of Surgical Oncology (SSO) panel convened to develop recommendations…
Beyond bacteria: How the intratumor mycobiome modulates lung adenocarcinoma progression
Increasing evidence suggests that tumors harbor diverse microbiomes, adding complexity to the tumor microenvironment. In this issue of Cancer Cell, Liu etย al. highlight the role…
Merck Announces Phase 3 KEYNOTE-756 Trial Met Primary Endpoint of Pathological Complete Response (pCR) Rate in Patients With High-Risk, Early-Stage ER+/HER2- Breast Cancer – Merck.com
KEYTRUDAยฎ (pembrolizumab) plus chemotherapy before surgery significantly improved pCR rate compared to neoadjuvant placebo plus chemotherapy KEYNOTE-756 is the first positive Phase 3 study with…
